Please provide your email address to receive an email when new articles are posted on . WASHINGTON — An early, 1-year course of methotrexate may prevent anti-citrullinated protein ...
Current therapies for rheumatoid arthritis rely on sustained immunosuppression rather than restoration of immune tolerance, with off-drug remission remaining rare.
MedPage Today on MSN
CAR T-cell trial in rheumatoid arthritis starts off strong
Strong initial responses in 4 of 6 patients after many standard drugs had failed ...
A promising new study suggests rheumatoid arthritis may not be as inevitable as once thought for people at high risk.
Please provide your email address to receive an email when new articles are posted on . SCOTTSDALE, Ariz. — Patients with rheumatoid arthritis who had a decrease in a certain type of B cell that fails ...
Breathing in common workplace dusts and fumes from agents such as vapours, gases, and solvents, may heighten the risk of developing rheumatoid arthritis, suggests research published online in the ...
Inhaling certain workplace dusts and fumes may heighten the risk of developing rheumatoid arthritis, a new study has found. Breathing in such particles — from agents such as vapors, gasses and ...
While disease activity improves over time for most rheumatoid arthritis (RA) patients, long-term outcomes only improve in RA patients with autoantibodies, according to a new study. The findings add to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results